TFS
BEAM icon

TrustCore Financial Services’s Beam Therapeutics BEAM Stock Holding History

TrustCore Financial Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$587 Hold
15
– – ﹤0.01% 964
2022
Q3 		$1K Hold
15
– – ﹤0.01% 987
2022
Q2 		$1K Hold
15
– – ﹤0.01% 973
2022
Q1 		$1K Hold
15
– – ﹤0.01% 979
2021
Q4 		$1K Hold
15
– – ﹤0.01% 898
2021
Q3 		$1K Hold
15
– – ﹤0.01% 977
2021
Q2 		$2K Hold
15
– – ﹤0.01% 923
2021
Q1 		$1K Sell
15
-143
-91% -$13.6K ﹤0.01% 881
2020
Q4 		$13K Buy
+158
New +$7.77K ﹤0.01% 630

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

TrustCore Financial Services's BEAM Position: Q4 2022 in Review

TrustCore Financial Services held its Beam Therapeutics (BEAM) position steady in Q4 2022 at 15 shares worth $587. The position accounts for ﹤0.01% of the portfolio, ranked #964.

TrustCore Financial Services first reported a position in BEAM in Q4 2020 and has held it in 9 quarters since. The position peaked at $13K in Q4 2020. 209 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • TrustCore Financial Services held 15 shares of Beam Therapeutics worth $587 as of Q4 2022.
  • TrustCore Financial Services left its Beam Therapeutics share count unchanged in Q4 2022.
  • Beam Therapeutics made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #964 holding.
  • TrustCore Financial Services first reported a position in Beam Therapeutics in Q4 2020 and has held it in 9 quarters since.
  • TrustCore Financial Services's Beam Therapeutics position peaked at $13K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.